Related Experiment Video
Updated: Aug 6, 2026

07:50
2D-HPLC-MS Technology Combined with Molecular Network for the Identification of Components in Tibetan Medicine Aconitum pendulum
Published on: December 8, 2023
Anticoagulant from Taraxacum platycarpum
Soo-In Yun1, Hong-Rae Cho, Hye-Seon Choi
1Department of Biological Sciences and Immunomodulation Research Center, University of Ulsan, Korea.
Bioscience, Biotechnology, and Biochemistry
|October 29, 2002
Summary
Researchers purified an anticoagulant protein from Taraxacum platycarpum. This novel protein inhibits thrombin and kallikrein, impacting blood coagulation and inflammatory pathways.
Area of Science:
- Biochemistry
- Pharmacology
- Natural Products
Background:
- Taraxacum platycarpum, a Chinese herb, has been traditionally used for medicinal purposes.
- Understanding the molecular mechanisms of plant-derived anticoagulants is crucial for developing new therapeutic agents.
Purpose of the Study:
- To isolate and characterize a novel anticoagulant protein from Taraxacum platycarpum.
- To investigate the biochemical properties and mechanism of action of the purified protein.
- To explore the protein's effects on inflammatory pathways in macrophage cell lines.
Main Methods:
- Protein purification using chromatographic techniques.
- Enzyme activity assays including thrombin time, prothrombin time, and activated partial thromboplastin time.
- Molecular weight determination via gel filtration and SDS-PAGE.
- Inhibition assays with specific proteases and substrates.
- Analysis of protein interaction with thrombin using binding studies.
- Murine macrophage cell line (Raw 264.7) stimulation assays to assess inflammatory mediator production.
Main Results:
- A heat-labile anticoagulant protein with a molecular mass of approximately 31-33 kDa was purified.
- The protein significantly prolonged thrombin time, prothrombin time, and activated partial thromboplastin time.
- It was identified as a thrombin and kallikrein inhibitor, binding to thrombin's anion-binding exosite.
- The protein did not hydrolyze fibrinogen.
- In Raw 264.7 cells, the protein induced the production of cyclooxygenase-2, nitric oxide synthase, nitric oxide, and tumor necrosis factor-alpha.
Conclusions:
- Taraxacum platycarpum contains a potent anticoagulant protein that functions by inhibiting thrombin.
- The protein's interaction with thrombin suggests a specific mechanism of action relevant to coagulation.
- The induction of inflammatory mediators indicates a potential dual role in coagulation and inflammation, warranting further investigation.
Related Concept Videos
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

